Understanding what deep learning (DL) models learn is essential for the safe deployment of artificial intelligence (AI) in clinical settings. While previous work has focused on pixel-based explainability methods, less attention has been paid to the textual concepts learned by these models, which may better reflect the reasoning used by clinicians. We introduce Mammo-CLIP Dissect, the first concept-based explainability framework for systematically dissecting DL vision models trained for mammography. Leveraging a mammography-specific vision-language model (Mammo-CLIP) as a "dissector," our approach labels neurons at specified layers with human-interpretable textual concepts and quantifies their alignment to domain knowledge. Using Mammo-CLIP Dissect, we investigate three key questions: (1) how concept learning differs between DL vision models trained on general image datasets versus mammography-specific datasets; (2) how fine-tuning for downstream mammography tasks affects concept specialisation; and (3) which mammography-relevant concepts remain underrepresented. We show that models trained on mammography data capture more clinically relevant concepts and align more closely with radiologists' workflows than models not trained on mammography data. Fine-tuning for task-specific classification enhances the capture of certain concept categories (e.g., benign calcifications) but can reduce coverage of others (e.g., density-related features), indicating a trade-off between specialisation and generalisation. Our findings show that Mammo-CLIP Dissect provides insights into how convolutional neural networks (CNNs) capture mammography-specific knowledge. By comparing models across training data and fine-tuning regimes, we reveal how domain-specific training and task-specific adaptation shape concept learning. Code and concept set are available: https://github.com/Suaiba/Mammo-CLIP-Dissect.

Breast cancer screening with mammography remains central to early detection and mortality reduction. Deep learning has shown strong potential for automating mammogram interpretation, yet limited-resolution datasets and small sample sizes continue to restrict performance. We revisit the Mini-DDSM dataset (9,684 images; 2,414 patients) and introduce a lightweight region-of-interest (ROI) augmentation strategy. During training, full images are probabilistically replaced with random ROI crops sampled from a precomputed, label-free bounding-box bank, with optional jitter to increase variability. We evaluate under strict patient-level cross-validation and report ROC-AUC, PR-AUC, and training-time efficiency metrics (throughput and GPU memory). Because ROI augmentation is training-only, inference-time cost remains unchanged. On Mini-DDSM, ROI augmentation (best: p_roi = 0.10, alpha = 0.10) yields modest average ROC-AUC gains, with performance varying across folds; PR-AUC is flat to slightly lower. These results demonstrate that simple, data-centric ROI strategies can enhance mammography classification in constrained settings without requiring additional labels or architectural modifications.

Breast cancer, the second leading cause of cancer-related deaths globally, accounts for a quarter of all cancer cases [1]. To lower this death rate, it is crucial to detect tumors early, as early-stage detection significantly improves treatment outcomes. Advances in non-invasive imaging techniques have made early detection possible through computer-aided detection (CAD) systems which rely on traditional image analysis to identify malignancies. However, there is a growing shift towards deep learning methods due to their superior effectiveness. Despite their potential, deep learning methods often struggle with accuracy due to the limited availability of large-labeled datasets for training. To address this issue, our study introduces a Contrastive Learning (CL) framework, which excels with smaller labeled datasets. In this regard, we train Resnet-50 in semi supervised CL approach using similarity index on a large amount of unlabeled mammogram data. In this regard, we use various augmentation and transformations which help improve the performance of our approach. Finally, we tune our model on a small set of labelled data that outperforms the existing state of the art. Specifically, we observed a 96.7% accuracy in detecting breast cancer on benchmark datasets INbreast and MIAS.

Breast cancer is the most commonly diagnosed cancer and the leading cause of cancer-related mortality in women globally. Mammography is essential for the early detection and diagnosis of breast lesions. Despite recent progress in foundation models (FMs) for mammogram analysis, their clinical translation remains constrained by several fundamental limitations, including insufficient diversity in training data, limited model generalizability, and a lack of comprehensive evaluation across clinically relevant tasks. Here, we introduce VersaMammo, a versatile foundation model for mammograms, designed to overcome these limitations. We curated the largest multi-institutional mammogram dataset to date, comprising 706,239 images from 21 sources. To improve generalization, we propose a two-stage pre-training strategy to develop VersaMammo, a mammogram foundation model. First, a teacher model is trained via self-supervised learning to extract transferable features from unlabeled mammograms. Then, supervised learning combined with knowledge distillation transfers both features and clinical knowledge into VersaMammo. To ensure a comprehensive evaluation, we established a benchmark comprising 92 specific tasks, including 68 internal tasks and 24 external validation tasks, spanning 5 major clinical task categories: lesion detection, segmentation, classification, image retrieval, and visual question answering. VersaMammo achieves state-of-the-art performance, ranking first in 50 out of 68 specific internal tasks and 20 out of 24 external validation tasks, with average ranks of 1.5 and 1.2, respectively. These results demonstrate its superior generalization and clinical utility, offering a substantial advancement toward reliable and scalable breast cancer screening and diagnosis.

Risk-adapted breast cancer screening requires robust models that leverage longitudinal imaging data. Most current deep learning models use single or limited prior mammograms and lack adaptation for real-world settings marked by imbalanced outcome distribution and heterogeneous follow-up. We developed LongiMam, an end-to-end deep learning model that integrates both current and up to four prior mammograms. LongiMam combines a convolutional and a recurrent neural network to capture spatial and temporal patterns predictive of breast cancer. The model was trained and evaluated using a large, population-based screening dataset with disproportionate case-to-control ratio typical of clinical screening. Across several scenarios that varied in the number and composition of prior exams, LongiMam consistently improved prediction when prior mammograms were included. The addition of prior and current visits outperformed single-visit models, while priors alone performed less well, highlighting the importance of combining historical and recent information. Subgroup analyses confirmed the model's efficacy across key risk groups, including women with dense breasts and those aged 55 years or older. Moreover, the model performed best in women with observed changes in mammographic density over time. These findings demonstrate that longitudinal modeling enhances breast cancer prediction and support the use of repeated mammograms to refine risk stratification in screening programs. LongiMam is publicly available as open-source software.

Mammography screening is an essential tool for early detection of breast cancer. The speed and accuracy of mammography interpretation have the potential to be improved with deep learning methods. However, the development of a foundation visual language model (VLM) is hindered by limited data and domain differences between natural and medical images. Existing mammography VLMs, adapted from natural images, often ignore domain-specific characteristics, such as multi-view relationships in mammography. Unlike radiologists who analyze both views together to process ipsilateral correspondence, current methods treat them as independent images or do not properly model the multi-view correspondence learning, losing critical geometric context and resulting in suboptimal prediction. We propose GLAM: Global and Local Alignment for Multi-view mammography for VLM pretraining using geometry guidance. By leveraging the prior knowledge about the multi-view imaging process of mammograms, our model learns local cross-view alignments and fine-grained local features through joint global and local, visual-visual, and visual-language contrastive learning. Pretrained on EMBED [14], one of the largest open mammography datasets, our model outperforms baselines across multiple datasets under different settings.

Numerous deep learning-based solutions have been developed for the automatic recognition of breast cancer using mammography images. However, their performance often declines when applied to data from different domains, primarily due to domain shift - the variation in data distributions between source and target domains. This performance drop limits the safe and equitable deployment of AI in real-world clinical settings. In this study, we present DoSReMC (Domain Shift Resilient Mammography Classification), a batch normalization (BN) adaptation framework designed to enhance cross-domain generalization without retraining the entire model. Using three large-scale full-field digital mammography (FFDM) datasets - including HCTP, a newly introduced, pathologically confirmed in-house dataset - we conduct a systematic cross-domain evaluation with convolutional neural networks (CNNs). Our results demonstrate that BN layers are a primary source of domain dependence: they perform effectively when training and testing occur within the same domain, and they significantly impair model generalization under domain shift. DoSReMC addresses this limitation by fine-tuning only the BN and fully connected (FC) layers, while preserving pretrained convolutional filters. We further integrate this targeted adaptation with an adversarial training scheme, yielding additional improvements in cross-domain generalizability. DoSReMC can be readily incorporated into existing AI pipelines and applied across diverse clinical environments, providing a practical pathway toward more robust and generalizable mammography classification systems.

Mammogram visual question answering (VQA) integrates image interpretation with clinical reasoning and has potential to support breast cancer screening. We systematically evaluated the GPT-5 family and GPT-4o model on four public mammography datasets (EMBED, InBreast, CMMD, CBIS-DDSM) for BI-RADS assessment, abnormality detection, and malignancy classification tasks. GPT-5 consistently was the best performing model but lagged behind both human experts and domain-specific fine-tuned models. On EMBED, GPT-5 achieved the highest scores among GPT variants in density (56.8%), distortion (52.5%), mass (64.5%), calcification (63.5%), and malignancy (52.8%) classification. On InBreast, it attained 36.9% BI-RADS accuracy, 45.9% abnormality detection, and 35.0% malignancy classification. On CMMD, GPT-5 reached 32.3% abnormality detection and 55.0% malignancy accuracy. On CBIS-DDSM, it achieved 69.3% BI-RADS accuracy, 66.0% abnormality detection, and 58.2% malignancy accuracy. Compared with human expert estimations, GPT-5 exhibited lower sensitivity (63.5%) and specificity (52.3%). While GPT-5 exhibits promising capabilities for screening tasks, its performance remains insufficient for high-stakes clinical imaging applications without targeted domain adaptation and optimization. However, the tremendous improvements in performance from GPT-4o to GPT-5 show a promising trend in the potential for general large language models (LLMs) to assist with mammography VQA tasks.

Breast cancer detection through mammography interpretation remains difficult because of the minimal nature of abnormalities that experts need to identify alongside the variable interpretations between readers. The potential of CNNs for medical image analysis faces two limitations: they fail to process both local information and wide contextual data adequately, and do not provide explainable AI (XAI) operations that doctors need to accept them in clinics. The researcher developed the MammoFormer framework, which unites transformer-based architecture with multi-feature enhancement components and XAI functionalities within one framework. Seven different architectures consisting of CNNs, Vision Transformer, Swin Transformer, and ConvNext were tested alongside four enhancement techniques, including original images, negative transformation, adaptive histogram equalization, and histogram of oriented gradients. The MammoFormer framework addresses critical clinical adoption barriers of AI mammography systems through: (1) systematic optimization of transformer architectures via architecture-specific feature enhancement, achieving up to 13% performance improvement, (2) comprehensive explainable AI integration providing multi-perspective diagnostic interpretability, and (3) a clinically deployable ensemble system combining CNN reliability with transformer global context modeling. The combination of transformer models with suitable feature enhancements enables them to achieve equal or better results than CNN approaches. ViT achieves 98.3% accuracy alongside AHE while Swin Transformer gains a 13.0% advantage through HOG enhancements

Content-based mammographic image retrieval systems require exact BIRADS categorical matching across five distinct classes, presenting significantly greater complexity than binary classification tasks commonly addressed in literature. Current medical image retrieval studies suffer from methodological limitations including inadequate sample sizes, improper data splitting, and insufficient statistical validation that hinder clinical translation. We developed a comprehensive evaluation framework systematically comparing CNN architectures (DenseNet121, ResNet50, VGG16) with advanced training strategies including sophisticated fine-tuning, metric learning, and super-ensemble optimization. Our evaluation employed rigorous stratified data splitting (50%/20%/30% train/validation/test), 602 test queries, and systematic validation using bootstrap confidence intervals with 1,000 samples. Advanced fine-tuning with differential learning rates achieved substantial improvements: DenseNet121 (34.79% precision@10, 19.64% improvement) and ResNet50 (34.54%, 19.58% improvement). Super-ensemble optimization combining complementary architectures achieved 36.33% precision@10 (95% CI: [34.78%, 37.88%]), representing 24.93% improvement over baseline and providing 3.6 relevant cases per query. Statistical analysis revealed significant performance differences between optimization strategies (p<0.001) with large effect sizes (Cohen's d>0.8), while maintaining practical search efficiency (2.8milliseconds). Performance significantly exceeds realistic expectations for 5-class medical retrieval tasks, where literature suggests 20-25% precision@10 represents achievable performance for exact BIRADS matching. Our framework establishes new performance benchmarks while providing evidence-based architecture selection guidelines for clinical deployment in diagnostic support and quality assurance applications.